E
Eric P. Krenning
Researcher at Erasmus University Rotterdam
Publications - 413
Citations - 37391
Eric P. Krenning is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Radionuclide therapy & Somatostatin. The author has an hindex of 103, co-authored 411 publications receiving 34109 citations. Previous affiliations of Eric P. Krenning include University Hospital Bonn & Novartis.
Papers
More filters
Journal ArticleDOI
Gastroenteropancreatic neuroendocrine tumours.
Irvin M. Modlin,Kjell Öberg,Daniel C. Chung,Robert T. Jensen,Wouter W. de Herder,Rajesh V. Thakker,Martyn Caplin,Gianfranco Delle Fave,Greg Kaltsas,Eric P. Krenning,Steven F. Moss,Ola Nilsson,Guido Rindi,Ramon Salazar,Philippe Ruszniewski,Anders Sundin +15 more
TL;DR: To improve outcome from GEP NETs, a better understanding of their biology is needed, with emphasis on molecular genetics and disease modeling, and more-reliable serum markers, better tumour localisation and identification of small lesions, and histological grading systems and classifications with prognostic application are needed.
Journal ArticleDOI
Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
Dik J. Kwekkeboom,Wouter W. de Herder,Boen L. Kam,Casper H.J. van Eijck,Martijn van Essen,P. P. M. Kooij,Richard A Feelders,Maarten O. van Aken,Eric P. Krenning +8 more
TL;DR: Treatment with peptide receptor radionuclide therapy with the radiolabeled somatostatin analog [(177)Lu-DOTA(0),Tyr(3)]octreotate has few adverse effects and compares favorably to the limited number of alternative treatment modalities.
Journal ArticleDOI
The role of somatostatin and its analogs in the diagnosis and treatment of tumors.
TL;DR: Experimental studies show that chronic administration of somatostatin analogs causes growth inhibition of a number of (transplantable) tumors in animals, including chondrosarcomas, pancreatic, prostatic, breast, and pituitary cancers.
Journal ArticleDOI
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
Marianne Pavel,Dermot O'Toole,Frederico Costa,Jaume Capdevila,David J. Gross,Reza Kianmanesh,Eric P. Krenning,Ulrich Knigge,Ramon Salazar,Ulrich-Frank Pape,Kjell Öberg +10 more
TL;DR: The goal of this paper is to update a more extensive review and guidelines paper published in 2012 with any pertinent update pertaining to the diagnosis and staging of individual prima prima cancer patients.
Journal ArticleDOI
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.
Marianne Pavel,Eric Baudin,Anne Couvelard,Eric P. Krenning,Kjell Öberg,Thomas Steinmüller,Martin Anlauf,Bertram Wiedenmann,Ramon Salazar +8 more
TL;DR: ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, MidGut, Hind gut, and Unknown Primary